TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 905127

Group type: EXPERIMENTAL
Intervention: Digoxin 20 microgram/kg/day (loading dose of 20 microgram/kg followed by maintenance dose of 7 microgram/kg every 8 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Digoxin levels exceeding 5 ng/ml
Number of subjects: 0
Study: 31358093

Group type: EXPERIMENTAL
Intervention: Amphotericin B nasal irrigation
Number of subjects: 87

Group type: COMPARATOR
Intervention: Saline nasal irrigation (placebo)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Serum IgE levels preoperatively
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Comparison of pre and postoperative serum IgE levels
Number of subjects: 87
Study: 28712113

Group type: EXPERIMENTAL
Intervention: Nutritional assessment and management
Number of subjects: 1742

Group type: COMPARATOR
Intervention: Receiving tuberculosis treatment
Number of subjects: 1742

Group type: EXPERIMENTAL
Intervention: Fat-free mass index, mid-upper arm circumference, haemoglobin, systolic blood pressure
Number of subjects: 1742

Group type: EXPERIMENTAL
Intervention: Fat mass index in men
Number of subjects: 1742

Group type: EXPERIMENTAL
Intervention: C-reactive protein and CD4 count
Number of subjects: 1742
Study: 26158605

Group type: EXPERIMENTAL
Intervention: Testosterone solution 2% (60 mg applied to the axillae for 16 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (applied to the axillae for 16 weeks)
Number of subjects: 76
Study: 23006335

Group type: EXPERIMENTAL
Intervention: Sensorimotor adaptation training with a rotating visual scene
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group with static scene
Number of subjects: 16
Study: 22067312

Group type: EXPERIMENTAL
Intervention: Adjusted dose (AD) of mycophenolate mofetil (MMF) using therapeutic drug monitoring (TDM)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Fixed-dose (FD) regimen of mycophenolate mofetil (MMF)
Number of subjects: 247
Study: 19421770

Group type: EXPERIMENTAL
Intervention: FloSeal (5,000 U/5 mL)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Tabotamp (oxidized regenerated cellulose patch, 2.5 x 5 cm)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Surgical procedures only
Number of subjects: 155
Study: 17054603

Group type: EXPERIMENTAL
Intervention: Free testing strips for 6 months
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control group (no free testing strips)
Number of subjects: 262
Study: 15283801

Group type: EXPERIMENTAL
Intervention: Itraconazole (5 mg/kg/day, continuous regimen, either as capsule or oral suspension)
Number of subjects: 163
Study: 10791448

Group type: EXPERIMENTAL
Intervention: Early discharge to hospital-at-home (n = 93)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Usual hospital care and discharge (n = 40)
Number of subjects: 133
Study: 8791962

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg b.d.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 1958942

Group type: EXPERIMENTAL
Intervention: Three treatment regimes (behavioural approach to diet and weight gain coupled with individual and family psychotherapy)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Three treatment regimes
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 90
Study: 7053265

Group type: EXPERIMENTAL
Intervention: CTP (cyclophosphamide 400 mg/m2/day orally X 5, teniposide 100 mg/m2 iv X 1, prednisolone 60 mg/m2/day orally X 5)
Number of subjects: 164

Group type: COMPARATOR
Intervention: COP (vincristine 1.4 mg/m2 iv X 1; maximum, 2 mg, with the same cyclophosphamide and prednisolone doses)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: CTP
Number of subjects: 164

Group type: COMPARATOR
Intervention: COP
Number of subjects: 164
Study: 31733459

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31192716

Group type: EXPERIMENTAL
Intervention: COMMASH-E intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 58
Study: 28683300

Group type: EXPERIMENTAL
Intervention: Albiglutide
Number of subjects: 3132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3132

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 3132

Group type: COMPARATOR
Intervention: Pioglitazone
Number of subjects: 3132

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 3132

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 3132
Study: 25342246

Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard treatment (normothermic)
Number of subjects: 90
Study: 25072757

Group type: EXPERIMENTAL
Intervention: Simplified Severe Sepsis Protocol (up to 4 L of IV fluids within 6 hours, guided by jugular venous pressure assessment, and dopamine and/or blood transfusion in selected patients)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (managed as usual care)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Simplified Severe Sepsis Protocol
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study: 22103452

Group type: EXPERIMENTAL
Intervention: isoflurane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: sevoflurane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: desflurane
Number of subjects: 12
Study: 20574796

Group type: EXPERIMENTAL
Intervention: Cryoplasty (group CRYO; 24 patients with 31 lesions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (group COBA; 26 patients with 34 lesions)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cryoplasty (group CRYO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (group COBA)
Number of subjects: 50
Study: 18047458

Group type: EXPERIMENTAL
Intervention: 30 minutes daily stretch of the wrist and finger flexors five days a week for four weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine upper-limb retraining five days a week
Number of subjects: 40
Study: 16032447

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Caudal analgesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control/Placebo
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control/Flumazenil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Caudal/Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Caudal/Flumazenil
Number of subjects: 60
Study: 12086029

Group type: EXPERIMENTAL
Intervention: Dynamic (Capener) splints
Number of subjects: 24

Group type: COMPARATOR
Intervention: Static (belly gutter) splints
Number of subjects: 24
Study: 10420149

Group type: EXPERIMENTAL
Intervention: Bicalutamide (50 mg once daily) plus LHRHa (goserelin acetate 3.6 mg or leuprolide acetate 7.5 mg)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Flutamide (250 mg three times daily) plus LHRHa (goserelin acetate 3.6 mg or leuprolide acetate 7.5 mg)
Number of subjects: 813
Study: 7593526

Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg) plus sulprostone (250 micrograms)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Vacuum aspiration
Number of subjects: 381
Study: 2489853

Group type: EXPERIMENTAL
Intervention: Interactive Videodisc (IVD)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Teacher-Directed (TD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Self-Directed (SD)
Number of subjects: 54
Study: 4583183

Group type: EXPERIMENTAL
Intervention: Vagotomy and pyloroplasty
Number of subjects: 100

Group type: COMPARATOR
Intervention: Billroth I partial gastrectomy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 100
Study: 31880181

Group type: EXPERIMENTAL
Intervention: Rational-emotive adult education intervention (REAEI) delivered in 32 group therapeutic sessions over 16 weeks
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 320
Study: 29800331

Group type: EXPERIMENTAL
Intervention: Regular cigarette
Number of subjects: 998

Group type: EXPERIMENTAL
Intervention: Slim cigarette
Number of subjects: 998

Group type: EXPERIMENTAL
Intervention: Pink cigarette
Number of subjects: 998

Group type: COMPARATOR
Intervention: Plain gray cigarette
Number of subjects: 998
Study: 28478791

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 26598451

Group type: EXPERIMENTAL
Intervention: Stochastic resonance (SR) stimulation
Number of subjects: 36

Group type: COMPARATOR
Intervention: No SR stimulation (control)
Number of subjects: 36
Study: 23124914

Group type: EXPERIMENTAL
Intervention: Topical sialogogue spray containing 1% malic acid
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 70
Study: 21706268

Group type: EXPERIMENTAL
Intervention: Online social network (OSN) usage
Number of subjects: 3012

Group type: EXPERIMENTAL
Intervention: Friend requests from patients or their family members
Number of subjects: 3012

Group type: EXPERIMENTAL
Intervention: Ethical acceptability of interacting with patients within OSNs
Number of subjects: 3012

Group type: EXPERIMENTAL
Intervention: Pessimism about OSNs improving patient-doctor communication
Number of subjects: 3012

Group type: EXPERIMENTAL
Intervention: Concerns about maintaining patient confidentiality
Number of subjects: 3012
Study: 19218542

Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER 20 to 40 mg/d
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study: 21744967

Group type: EXPERIMENTAL
Intervention: Individually tailored, multicomponent intervention
Number of subjects: 841

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 841
Study: 16052676

Group type: EXPERIMENTAL
Intervention: Recombinant human IFN beta‐1a alone (Group 1)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Recombinant human IFN beta‐1a in combination with ribavirin (Group 2)
Number of subjects: 102
Study: 12444323

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) regimen 1 starting with 3 IR tablets (n = 15)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) regimen 2 starting with 10 IR tablets (n = 16)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) regimen 3 starting with 30 IR tablets (n = 16)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (n = 16)
Number of subjects: 64
Study: 9635520

Group type: EXPERIMENTAL
Intervention: Controlled-release (CR) morphine tablets administered every 12 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release (IR) morphine
Number of subjects: 0
Study: 8076658

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 2499233

Group type: EXPERIMENTAL
Intervention: Low CHO diet (10% calories from CHO)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High CHO diet (70% calories from CHO)
Number of subjects: 8
Study: 4185887

Group type: EXPERIMENTAL
Intervention: Pretreatment with carbimazole
Number of subjects: 181

Group type: COMPARATOR
Intervention: Radioactive iodine (131)I therapy
Number of subjects: 181
Study: 11340104

Group type: EXPERIMENTAL
Intervention: High fiber meal containing white beans
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low fiber meal containing rice and dry milk
Number of subjects: 0
Study: 30203440

Group type: EXPERIMENTAL
Intervention: Bupivacaine 50 mg with adrenaline 100 μg (BA-group, n = 14)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bupivacaine without adrenaline (B-group, n = 16)
Number of subjects: 30
Study: 29446060

Group type: EXPERIMENTAL
Intervention: Midazolam group (20 ml of bupivacaine hydrochloride 0.25% + midazolam 50 μg/kg in 2 ml saline 0.9%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (20 ml of bupivacaine hydrochloride 0.25% + 2 ml saline)
Number of subjects: 60
Study: 27455035

Group type: EXPERIMENTAL
Intervention: CAM-positive delirium assessment using Confusion Assessment Method (CAM)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Delirium severity measured with Memorial Delirium Assessment Scale (MDAS)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Physician identification of delirium
Number of subjects: 243

Group type: COMPARATOR
Intervention: Comparison of delirium frequency in patients aged 65 and older vs. younger than 65
Number of subjects: 243
Study: 24231272

Group type: EXPERIMENTAL
Intervention: 100 m front-crawl style
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 200 m front-crawl style
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 400 m front-crawl style
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Stroke length (SL) and stroke index (SI)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Overall stroke parameters
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Anthropometrical variables (upper limbs and height)
Number of subjects: 46
Study: 21732090

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri SD2112 and PTA 5289
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 13
Study: 20170698

Group type: EXPERIMENTAL
Intervention: Yokukansan (YKS) combined with donepezil (7.5g, t.i.d.) for 4 weeks
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Yokukansan (YKS) combined with donepezil
Number of subjects: 61

Group type: COMPARATOR
Intervention: Non-Yokukansan (donepezil monotherapy)
Number of subjects: 61
Study: 18023787

Group type: EXPERIMENTAL
Intervention: multiple behavior health contract
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: one‐on‐one tailored consultation
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: combined consultation plus contract intervention
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: consultation or consultation plus contract
Number of subjects: 155
Study: 15771029

Group type: EXPERIMENTAL
Intervention: Iloprost (synthetic prostacyclin analogue)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12472618

Group type: EXPERIMENTAL
Intervention: Lidocaine-prilocaine cream 5% applied for 20 min
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lidocaine-prilocaine cream 5% applied for 30 min
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lidocaine-prilocaine cream 5% applied for 45 min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Base cream as placebo
Number of subjects: 40
Study: 18653121

Group type: EXPERIMENTAL
Intervention: Folic acid treatment for 60 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7808833

Group type: EXPERIMENTAL
Intervention: Postural change from supine to standing position
Number of subjects: 20
Study: 2573295

Group type: COMPARATOR
Intervention: Adrenaline infusion after placebo pretreatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion after atenolol pretreatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion after propranolol pretreatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion after beta-2-selective beta-blocking agent (ICI 118551)
Number of subjects: 12
Study: 805621

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no antibiotic)
Number of subjects: 100
Study: 29561428

Group type: EXPERIMENTAL
Intervention: ChondroT 1.0 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ChondroT 2.0 g
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28205449

Group type: EXPERIMENTAL
Intervention: NTRK2 and COMT SNP genotypes
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: COMT variants
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: NTRK2 SNP rs1212171 genotype
Number of subjects: 51
Study: 25342376

Group type: EXPERIMENTAL
Intervention: ENT involvement
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Each added ENT symptom
Number of subjects: 414

Group type: COMPARATOR
Intervention: Other early disease manifestations (arthralgia/arthritis, cutaneous and lung involvement)
Number of subjects: 414
Study: 23506049

Group type: EXPERIMENTAL
Intervention: Internet-based program for preventing generalised anxiety, supervised by classroom teachers, completed during class periods over six weeks.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Internet-based program for preventing generalised anxiety, supervised by classroom teachers and an education officer from the local youth mental health centre, completed during class periods over six weeks.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait-list control condition (no intervention).
Number of subjects: 30
Study: 22081994

Group type: EXPERIMENTAL
Intervention: Complex quality improvement intervention for GPs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (Control group)
Number of subjects: 0
Study: 18652270

Group type: EXPERIMENTAL
Intervention: All Bond 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: XP-Bond
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Xeno III
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-Bond unfilled resin of All Bond 2 without primer application
Number of subjects: 0
Study: 16766414

Group type: EXPERIMENTAL
Intervention: Close friends' smoking
Number of subjects: 4576

Group type: EXPERIMENTAL
Intervention: Parents' smoking
Number of subjects: 4576

Group type: EXPERIMENTAL
Intervention: Older siblings' smoking
Number of subjects: 4576
Study: 12712245

Group type: EXPERIMENTAL
Intervention: 60 g resistant starch (Novelose 260)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control diet (no resistant starch)
Number of subjects: 10
Study: 10825109

Group type: EXPERIMENTAL
Intervention: THA using the intraoperative limb-length measuring device (Group B)
Number of subjects: 117

Group type: COMPARATOR
Intervention: THA without the measuring device (Group A)
Number of subjects: 117
Study: 8658094

Group type: EXPERIMENTAL
Intervention: Furosemide (1 mg/h)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 1996871

Group type: EXPERIMENTAL
Intervention: Surgery (curative resection or palliative resection)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Radiotherapy (5000 cGy in 20 fractions over 4 weeks or 6000 cGy in 30 fractions over 6 weeks)
Number of subjects: 31
Study: 6337668

Group type: EXPERIMENTAL
Intervention: Preventive intermittent calf compression
Number of subjects: 90

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Modified Charnley technique
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Posterior surgical approach
Number of subjects: 90
Study: 31427472

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29194764

Group type: EXPERIMENTAL
Intervention: 200 minutes of physical education per week
Number of subjects: 228
Study: 26886423

Group type: EXPERIMENTAL
Intervention: In vivo exposure
Number of subjects: 63

Group type: COMPARATOR
Intervention: Augmented Reality exposure
Number of subjects: 63
Study: 24451130

Group type: EXPERIMENTAL
Intervention: Lycopene-enriched diet (20-25 mg/day of lycopene; through 30 g/day of triple concentrated tomato paste) for 6 months
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Baseline PSA levels
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Rate of HGPIN progression to PC
Number of subjects: 32
Study: 22632574

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (Early-PN)
Number of subjects: 4640
Study: 20145061

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators (ICDs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 17716779

Group type: EXPERIMENTAL
Intervention: BLM (1mg/kg, max 60mg/body)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: OK-432 (0.2 KE/kg, max 10KE/body)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Cisplatin (80mg/m2) and Etoposide (80mg/m2)
Number of subjects: 102
Study: 15533546

Group type: EXPERIMENTAL
Intervention: Paraplegics
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tetraplegics
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control persons
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Female tetraplegics
Number of subjects: 32
Study: 12051113

Group type: EXPERIMENTAL
Intervention: Estradiol and sequential levonorgestrel (50 micrograms/day estradiol for 2 weeks followed by 50 micrograms/day estradiol-10 micrograms/day levonorgestrel for 2 weeks)
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Estradiol and sequential levonorgestrel (75 micrograms/day estradiol for 2 weeks followed by 75 micrograms/day estradiol-15 micrograms/day levonorgestrel for 2 weeks)
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Estradiol and sequential levonorgestrel (100 micrograms/day estradiol for 2 weeks followed by 100 micrograms/day estradiol-20 micrograms/day levonorgestrel for 2 weeks)
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: All three doses of the transdermal hormone replacement therapy
Number of subjects: 468
Study: 10354975

Group type: EXPERIMENTAL
Intervention: Single 350 V shock (15 pts)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Multiple shocks of increasing energy (15 pts)
Number of subjects: 30
Study: 8652176

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with appropriate selection of drugs, techniques, and needles
Number of subjects: 0
Study: 1741639

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hot water
Number of subjects: 0

Group type: COMPARATOR
Intervention: No fluid
Number of subjects: 0
Study: 6805714

Group type: EXPERIMENTAL
Intervention: Curettage and primary suture
Number of subjects: 114

Group type: COMPARATOR
Intervention: Simple drainage
Number of subjects: 114
Study: 29433682

Group type: EXPERIMENTAL
Intervention: Ethanol extract of sage, rosemary and melissa (SRM)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (ethanol extract of Myrrhis odorata)
Number of subjects: 44